The latest start-ups emerging from University College Dublin (UCD) will be showcased at the 2015 UCD VentureLaunch Accelerator Programme Showcase and Awards Evening which takes place later this week.

Five new high-tech and knowledge-intensive ventures (profiled below) will pitch at the Awards evening with the overall winner receiving a €25,000 prize fund.

Glyconostics is an animal diagnostic new venture utilising the power of glycan fingerprinting to enable the animal health sector to predict animal health outcomes, identify and effectively intervene in disease progression and address fertility issues. Founder: Professor Stephen Carrington, UCD School of Veterinary Medicine.

iBAM Technologies
The indirect Brainstem Activity Monitor (iBAM) is a non-contact technology that accurately measures a clinically significant high frequency, low amplitude, fixational eye motion called ocular microtremor. This solves clinically relevant biophysical measurement problems involving a number of neurological conditions such as drug delivery/dose performance and optimisation, or testing for early onset of neurological degenerative disorders e.g. Parkinson’s Disease. Founders: Professor John Sheridan and Dr James Ryle, UCD School of Electrical and Electronic Engineering.

MPP Technologies
Microwave Plasma Processing (MPP) Technologies has patented a microwave plasma process for the fabrication of metal-diamond composite grinding wheels and for medical device surface treatments. Products developed exhibit superior wear and performance properties and enhanced bio-compatibility beyond current state-of-the-art. Founders: Professor Denis Dowling and Dr Charlie Stallard, UCD School of Mechanical and Materials Engineering and Mike Fish.

Phision Therapeutics
Phision Therapeutics is developing novel, small molecule drugs for the treatment of retinal diseases, e.g.  age-related macular degeneration (AMD), which is the leading cause of vision loss in Western societies. These drug candidates have novel mechanisms of action with the potential to address key unmet needs and improve outcomes of patients suffering from avoidable vision loss. Founder: Dr Breandán Kennedy, UCD School of Biomolecular and Biomedical Science.

ProCara is a food characterisation new venture using proteomic and bioinformatic analytical methods to comprehensively characterise the molecular composition of food matrices. This proposition offers the food industry an opportunity to highlight the unique value of their products, to identify functional ingredients, and to ensure their products meet rigorous safety and quality standards that complies with necessary regulatory requirements. Founders: Dr Gerard Cagney and Dr Eugene Dillion, UCD School of Biomolecular and Biomedical Science.

Serial entrepreneur, John Byrne, founder and CEO of Corlytics will be the guest speaker at the event.

 The overall objective of the UCD VentureLaunch Accelerator Programme is to support the creation, and to accelerate the launch, of sustainable and profitable new ventures based on intellectual property emerging from UCD.

The programme aims is to equip UCD researchers with the knowledge, skills and understanding that is required to work as part of a team successfully leading a new commercial venture.

The annual UCD VentureLaunch Accelerator Programme, which is held at NovaUCD the Centre for New Ventures and Entrepreneurs, uses the Business Model Canvas approach to start-up development. The programme consists of ten 3-hour workshops, delivered over a 3-month period, and a series of one-to-one sessions with external experts in areas such as finance, marketing and customer validation.

N1516410-minPictured at NovaUCD are Professor John Sheridan and Dr James Ryle, UCD School of Electrical and Electronic Engineering, co-founders, iBAM Technologies, one of the five participating ventures on the 2015 UCD VentureLaunch Accelerator Programme.

Speaking in advance of the event Brendan Cremen, UCD Director of Enterprise and Commercialisation said, “Through the VentureLaunch Accelerator Programme we are supporting our researchers to accelerate the process of establishing new ventures to translate innovative ideas arising from UCD research programmes into new companies providing value-added products and services with global potential.”

He added, “A few weeks ago Logentries, a UCD spin-out company, was acquired by Rapid7 for $68 million. In 2010 Logentries won the equivalent programme to VentureLaunch and our next ‘Logentries’ could be amongst this year’s five finalists.”

The 2015 UCD VentureLaunch Accelerator Showcase and Awards Evening takes place on Wednesday, 18 November, in the UCD O’Brien Centre for Science, UCD, Belfield, Dublin 4.

It commences at 5:15 pm when attendees will have the opportunity to meet with and talk to the founders of the new ventures during a showcase event. During the main awards event, which commences at 6 pm, the founders of each new venture will deliver a pitch to an audience comprising members of Ireland’s venture capital, research, state agencies, industry and business communities.

An overall winner, selected by the programme evaluation panel, will be presented with the 2015 UCD VentureLaunch Accelerator Award, a cheque for €10,000, and a professional services package to the value of €15,000. The prizes are sponsored by AIB, Bryan Maguire Business Consulting, Deloitte, and NovaUCD.

The members of the 2015 UCD VentureLaunch Accelerator Programme evaluation panel are Brendan Cremen, UCD Director of Enterprise and Commercialisation (chair); Dr Sharon O’Kane and Dr Sean Baker, NovaUCD Entrepreneurs in Residence in Life Sciences and ICT respectively; Dr Helen McBreen, Investment Director at Atlantic Bridge Capital and Dr Edward McDonnell, Director, CeADAR, the Centre for Applied Data Analytics Research.

All are welcome to register to attend the event via

The hashtag for the event is #VentureLaunch15.

Pin It on Pinterest

Share This

Share this post with your friends!